BrightAccountsProduction v1.0.0 v1.0.0 2024-08-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts Other professional, scientific and technical activities not elsewhere classifed. 30 November 2025 0 0 10289010 2025-07-31 10289010 2024-07-31 10289010 2023-07-31 10289010 2024-08-01 2025-07-31 10289010 2023-08-01 2024-07-31 10289010 uk-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 10289010 uk-curr:PoundSterling 2024-08-01 2025-07-31 10289010 uk-bus:FullAccounts 2024-08-01 2025-07-31 10289010 uk-bus:Director1 2024-08-01 2025-07-31 10289010 uk-bus:RegisteredOffice 2024-08-01 2025-07-31 10289010 uk-core:CapitalReserve 2025-07-31 10289010 uk-core:CapitalReserve 2024-07-31 10289010 2024-08-01 2025-07-31 10289010 uk-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 10289010 uk-bus:Micro-entities 2024-08-01 2025-07-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: 10289010

Ethika Healthcare Investments Limited

Unaudited Financial Statements

for the financial year ended 31 July 2025

Ethika Healthcare Investments Limited

DIRECTOR AND OTHER INFORMATION

Director | Eugene Kavanagh
Company Registration Number | 10289010
Registered Office | Unit 13b Business Centre,
| Boundary Way,
| Woking
| GU21 5DH
Business Address | Unit 13b Business Centre,
| Boundary Way,
| Woking,
| GU21 5DH
| England

Ethika Healthcare Investments Limited

INCOME STATEMENT

for the financial year ended 31 July 2025

| 2025 |  | 2024
| £ |  | £

Other charges | (1,201,344) |  | (1,057,849)
| ───────── |  | ─────────
Loss on ordinary activities before taxation | (1,201,344) |  | (1,057,849)
| ───────── |  | ─────────
Loss | (1,201,344) |  | (1,057,849)
| ═════════ |  | ═════════

Ethika Healthcare Investments Limited

Company Registration Number: 10289010

STATEMENT OF FINANCIAL POSITION

as at 31 July 2025

|  | 2025 |  | 2024
|  | £ |  | £
| Fixed Assets | 6,855,558 |  | 6,855,558
|  | ───────── |  | ─────────
| Current assets | 349,806 |  | 349,806
|  | ───────── |  | ─────────
| Total Assets less Current Liabilities | 7,205,364 |  | 7,205,364
| Creditors: amounts falling due after more than one year | (17,983,588) |  | (16,782,244)
|  | ───────── |  | ─────────
| Net Liabilities | (10,778,224) |  | (9,576,880)
|  | ═════════ |  | ═════════
| Capital and Reserves | (10,778,224) |  | (9,576,880)
|  | ═════════ |  | ═════════
| Notes to the Financial statements

1. | General Information
| Ethika Healthcare Investments Limited is a company limited by shares incorporated in England. The registered office of the company is Unit 13b Business Centre,, Boundary Way,, Woking, GU21 5DH. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Employees
| The average monthly number of employees, including director, during the financial year was 0, (2024 - 0).

| For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
| The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
| The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
| These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
| Approved by the Director on 30 November 2025 and signed by:
| ________________________________ |
| Eugene Kavanagh |
| Director |